By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS








Company News
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015 6:40:18 AM
AEterna Zentaris (AEZS) Announces Plans To Initiate Phase 3 Study Of Macrilen In AGHD Following Successful Meeting With FDA 4/13/2015 6:19:18 AM
AEterna Zentaris (AEZS) Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina 3/31/2015 6:08:42 AM
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2014 Financial And Operating Results 3/18/2015 7:56:16 AM
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015 8:46:58 AM
AEterna Zentaris (AEZS) To Announce Fourth Quarter And Full-Year 2014 Financial And Operating Results On March 17, 2015 3/10/2015 10:29:09 AM
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015 6:51:02 AM
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants 3/6/2015 6:40:04 AM
AEterna Zentaris (AEZS) To Present At Upcoming Biotech Showcase Conference In San Francisco 1/6/2015 9:36:23 AM
AEterna Zentaris (AEZS): Final Data For Phase 1 Portion Of Ongoing Phase 1/2 Trial With Zoptarelin Doxorubicin In Prostate Cancer Published In Clinical Cancer Research 12/29/2014 7:42:34 AM
12345678910...
//-->